 Last Call! Have you submitted your abstract for IEEE NAP-2025 yet? Join us at the International Symposium on "The MXene Frontier: Transformative Nanomaterials Shaping the Future" – the largest MXene-focused conference in Europe this year! Final Submission Deadline: May 15, 2025. Don’t miss this exclusive opportunity to showcase your research and engage with world leaders in the MXene field!
|
|
|
 We are excited to announce the publication of latest review article on MXenes in Healthcare. This comprehensive review explores the groundbreaking role of MXenes—an emerging class of 2D materials—in revolutionizing the fields of medical diagnostics and therapeutics. Read the full article here: https://doi.org/10.1039/D4NR04853A.
|
|
|
 Congratulations and thank you to our collaborators from TU Wien and CEST for very interesting work and making it published! In this work, an upscalable electrochemical MXene synthesis is presented. Yields of up to 60% electrochemical MXene (EC-MXene) with no byproducts from a single exfoliation cycle are achieved.
|
|
|
 Congratulations to all collaborators with this interesting joint work!
MXenes are among the most diverse and prominent 2D materials. They are being explored in almost every field of science and technology, including biomedicine. Despite their proven biocompatibility and low cytotoxicity, their genotoxicity has not been addressed, so we investigated whether MXenes interfere with DNA integrity in cultured cells and examined the fragmentation of their chromosomal DNA by a DNA comet assay.
|
|
|
 Thank you to our collaborators for the amazing joint work recently published in Graphene and 2D Nanomaterials about MXene–silk fibroin composite films aiming to develop materials with tunable electronic and thermal properties
|
|
|
 Dr. Oleksiy Gogotsi, director of MRC and Carbon-Ukraine, innovative companies that are among the leaders on the world MXene market, visited 2024 MRS Fall Meeting & Exhibit. together with Dr. Maksym Pogorielov, Head of Advanced Biomaterials and Biophysics Laboratory, University of Latvia.
|
|
|
We are proud to present our collaborative paper on an electrochemical real-time sensor for the selective detection of Pb(II) ions, powered by Ti₃C₂Tₓ MXene. Big thank you to our collaborators from Vilnius for extensive experiments and to make it published! This work lays the foundation for further development of in situ electrochemical sensors based on MXenes and their potential integration into lab-on-a-chip systems, enabling fast, portable, and cost-effective measurements for a wide range of applications.
|
|
|
 MRC and Carbon-Ukraine team visited the 3rd International MXene conference held at Drexel University on August 5-8, 2024. Conference brought together the best reserchers and leading experts on MXene field.
|
|
|
Looking forward to work together with Dr. Lyubov Titova and Dr. Jeannine Coubourne from Worcester Polytechnic Institute on structural and biomedical applications of MXenes and study of their properties within HORIZON EUROPE MSCA RISE ESCULAPE project!
|
|
|
 Together with colleagues from the University of Latvia, MRC/Carbone Ukraine, Adam Mickiewicz University, University Clinic Essen, and others, we have developed a novel concept involving the binding of antibodies to MXenes. In our research, we utilized anti-CEACAM1 antibodies to develop targeted photo-thermal therapy for melanoma (in vitro), paving the way for future in vivo studies and clinical trials. For the first time, we demonstrate the feasibility of delivering MXenes specifically targeted to melanoma cells, enabling the effective ablation of cancer cells under near-infrared (NIR) light. This new technique opens up vast potential for the application of MXenes in cancer treatment, diagnostics, drug delivery, and many other medical purposes.
|
|
|
Looking forward our collaboration with Dr. Vladimir Tsukruk's team from Georgia Tech University in trilateral research project IMPRESS-U, involving teams from Ukraine, Latvia, and the United States funded by National Science Foundation (NSF). project is focused on MXene-Based Composite Bio-membranes with Tailored Properties. Can't wait our Kick-off meeting that will be held at Latvias University in Riga with all project participants.
|
|
|
 In this study, we have optimized the synthesis of MAX phases for MXene manufacturing. The main purpose of this study is to develop a porous Ti3AlC2MAX phase that can be easily ground into individual grains manually without time-consuming eliminating the need for drilling and intenseball-milling before MXene synthesis. Moreover, we also demonstrate the synthesis of highly porous Ti3AlC2 (about 70%) from an inexpensive raw materials.
|
|
|
 Here we demonstrate a new developed method for depositing Ti3C2Tx MXenes onto hydrophobic electrospun PCL membranes using oxygen plasma treatment. These novel patches hold tremendous potential for providing mechanical support to damaged heart tissue and enabling electrical signal transmission,thereby mimicking the crucial electroconductivity required for normal cardiac function. After a detailed investigation of scaffold-to-cell interplay, including electrical stimulation, novel technology has the potential for clinical application not only for cardiac regeneration, but also as neural and muscular tissue substitutes.
|
|
|
 The rise of the Internet of Things has spurred extensive research on integrating conductive materials into textiles to turn them into sensors, antennas, energy storage devices, and heaters. MXenes, owing to their high electrical conductivity and solution processability, offer an efficient way to add conductivity and electronic functions to textiles. Here, a versatile automated yarn dip coater tailored for producing continuously high-quality MXene-coated yarns and conducted the most comprehensive MXene-yarn dip coating study to date is developed.
|
|
|
 MX-MAP project participants from MRC Dr. Oleksiy Gogotsi and Veronika Zahorodna performed split secondment visit to project partner organization University of Padova (Italy). MX-MAP project works on development of the key strategies for MXene medical applications.
|
|
|
